Brain regions associated with cognitive impairment in patients with parkinson disease: Quantitative analysis of cerebral blood flow using 123i iodoamphetamine SPECT

Clinical Nuclear Medicine

Volumn 38, Issue 5, 2013, Pages 315-320

  Hattori, Naoya ^a   Yabe, Ichiro ^a   Hirata, Kenji ^a   Shiga, Tohru ^a   Sakushima, Ken ^a   Tsuji Akimoto, Sachiko ^a   Sasaki, Hidenao ^a   Tamaki, Nagara ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

123I iodoamphetamine; Parkinson disease; quantitative analysis; regional cerebral blood flow (rCBF); SPECT

Indexed keywords

IOFETAMINE I 123; LEVODOPA;

ADULT; AGED; ANTERIOR CINGULATE; ARTICLE; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN DAMAGE; BRAIN REGION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; HUMAN; MALE; PARKINSON DISEASE; QUANTITATIVE ANALYSIS; QUANTITATIVE STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL CORTEX; VOXEL BASED MORPHOMETRY;

AGED; AGED, 80 AND OVER; AMPHETAMINES; BRAIN; CEREBROVASCULAR CIRCULATION; COGNITION; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; REGIONAL BLOOD FLOW; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84876418889     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3182873511     Document Type: Article

References (33)

1. Brown RG, Marsden CD. How common is dementia in Parkinson's disease? Lancet. 1984;2:1262-1265. (Pubitemid 15217727)
2. Aarsland D, Larsen JP, Lim NG, et al. Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 1999;67: 492-496. (Pubitemid 29438205)
3. Aarsland D, Tandberg E, Larsen JP, et al. Frequency of dementia in Parkinson disease. Arch Neurol. 1996;53:538-542. (Pubitemid 26177134)
4. Sawada H, Udaka F, Kameyama M, et al. SPECT findings in Parkinson's disease associated with dementia. J Neurol Neurosurg Psychiatry. 1992;55:960-963.
5. Liu RS, Lin KN, Wang SJ, et al. Cognition and 99Tcm-HMPAO SPECT in Parkinson's disease. Nucl Med Commun. 1992;13:744-748.
6. Defebvre LJ, Leduc V, Duhamel A, et al. Technetium HMPAO SPECT study in dementia with Lewy bodies, Alzheimer's disease and idiopathic Parkinson's disease. J Nucl Med. 1999;40:956-962. (Pubitemid 29269214)
7. Antonini A, De Notaris R, Benti R, et al. Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson's disease. Neurol Sci. 2001;22:45-46. (Pubitemid 33622083)
8. Derejko M, Slawek J, Wieczorek D, et al. Regional cerebral blood flow in Parkinson's disease as an indicator of cognitive impairment. Nucl Med Commun. 2006;27:945-951. (Pubitemid 44706889)
9. Borghammer P, Cumming P,Aanerud J, et al.Artefactual subcortical hyperperfusion in PET studies normalized to global mean: lessons from Parkinson's disease. Neuroimage. 2009;45:249-257.
10. Grunder G. "Absolute" or "relative": choosing the right outcome measure in neuroimaging. Neuroimage. 2009;45:258-259.
11. Borghammer P, Chakravarty M, Jonsdottir KY, et al. Cortical hypometabolism and hypoperfusion in Parkinson's disease is extensive: probably even at early disease stages. Brain Struct Funct. 2010;214:303-317.
12. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65: 1863-1872. (Pubitemid 43970103)
13. Hurtig HI, Trojanowski JQ, Galvin J, et al. Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology. 2000;54:1916-1921. (Pubitemid 30327112)
14. Daniel SE, Lees AJ. Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl. 1993;39:165-172. (Pubitemid 23216938)
15. Kouris K, Clarke GA, Jarritt PH, et al. Physical performance evaluation of the Toshiba GCA-9300A triple-headed system. J Nucl Med. 1993;34:1778-1789. (Pubitemid 23295394)
16. Iida H, Itoh H, Bloomfield PM, et al. A method to quantitate cerebral blood flow using a rotating gamma camera and iodine-123 iodoamphetamine with one blood sampling. Eur J Nucl Med. 1994;21:1072-1084. (Pubitemid 24304433)
17. Talairach J, Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain: 3-D Proportional System: An Approach to Cerebral Imaging (Thieme Classics). Stuttgart, NY: Thieme; 1988.
18. Minoshima S, Berger KL, Lee KS, et al. An automated method for rotational correction and centering of three-dimensional functional brain images. J Nucl Med. 1992;33:1579-1585.
19. Minoshima S, Koeppe RA, Mintun MA, et al. Automated detection of the intercommissural line for stereotactic localization of functional brain images. J Nucl Med. 1993;34:322-329. (Pubitemid 23056418)
20. Iida H, Itoh H, Nakazawa M, et al. Quantitative mapping of regional cerebral blood flow using iodine-123-IMP and SPECT. J Nucl Med. 1994;35:2019-2030. (Pubitemid 24376622)
21. Iida H, Akutsu T, Endo K, et al. A multicenter validation of regional cerebral blood flow quantitation using [123I]iodoamphetamine and single photon emission computed tomography. J Cereb Blood Flow Metab. 1996;16:781-793. (Pubitemid 26292046)
22. Pizzolato G, Dam M, Borsato N, et al. [99mTc]-HM-PAO SPECT in Parkinson's disease. J Cereb Blood Flow Metab. 1988;8:S101-S108.
23. Kasama S, Tachibana H, Kawabata K, et al. Cerebral blood flow in Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease according to threedimensional stereotactic surface projection imaging. Dement Geriatr Cogn Disord. 2005;19:266-275. (Pubitemid 40663320)
24. Spampinato U, Habert MO, Mas JL, et al. (99mTc)-HM-PAO SPECT and cognitive impairment in Parkinson's disease: a comparison with dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry. 1991;54:787-792.
25. Takahashi K, Yamaguchi S, Kobayashi S, et al. Effects of aging on regional cerebral blood flowassessed by using technetiumTc 99m hexamethylpropyleneamine oxime single-photon emission tomography with 3D stereotactic surface projection analysis. AJNR Am J Neuroradiol. 2005;26:2005-2009.
26. Bush G, Luu P, Posner MI. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci. 2000;4:215-222. (Pubitemid 30332147)
27. Buchsbaum BR, Greer S, Chang WL, et al. Meta-analysis of neuroimaging studies of theWisconsin card-sorting task and component processes. Hum Brain Mapp. 2005;25:35-45. (Pubitemid 40656191)
28. Ko JH, Ptito A, Monchi O, et al. Increased dopamine release in the right anterior cingulate cortex during the performance of a sorting task: a [11C]FLB 457 PET study. Neuroimage. 2009;46:516-521.
29. Emre M. Dementia in Parkinson's disease: cause and treatment. Curr Opin Neurol. 2004;17:399-404. (Pubitemid 39071415)
30. Aarsland D, Litvan I, Salmon D, et al. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2003;74:1215-1220.
31. Ito K, Nagano-Saito A, Kato T, et al. Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[18F]fluoro-L-dopa PET study. Brain. 2002;125:1358-1365. (Pubitemid 34587144)
32. Kalaitzakis ME, Christian LM, Moran LB, et al. Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease. Parkinsonism Relat Disord. 2009;15:196-204.
33. Hatazawa J, Iida H, Shimosegawa E, et al. Regional cerebral blood flow measurement with iodine-123-IMP autoradiography: normal values, reproducibility and sensitivity to hypoperfusion. J Nucl Med. 1997;38:1102-1108. (Pubitemid 27339618)